Dow Jones

40,003.59

0.34%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ALEC

Alector (ALEC)

Alector Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALEC

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
09/05/2024	06:00	GlobeNewswire Inc.	Alector to Participate in Upcoming Healthcare Conferences	NASDAQ:ALEC	Alector Inc
08/05/2024	15:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALEC	Alector Inc
08/05/2024	15:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALEC	Alector Inc
08/05/2024	15:05	GlobeNewswire Inc.	Alector Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ALEC	Alector Inc
05/03/2024	17:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALEC	Alector Inc
01/03/2024	18:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALEC	Alector Inc
27/02/2024	15:41	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALEC	Alector Inc
27/02/2024	15:05	GlobeNewswire Inc.	Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:ALEC	Alector Inc
20/02/2024	15:05	GlobeNewswire Inc.	Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call	NASDAQ:ALEC	Alector Inc
08/02/2024	17:59	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ALEC	Alector Inc
08/02/2024	06:00	GlobeNewswire Inc.	Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease	NASDAQ:ALEC	Alector Inc
07/02/2024	06:00	GlobeNewswire Inc.	FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)	NASDAQ:ALEC	Alector Inc
19/01/2024	08:20	GlobeNewswire Inc.	Alector Announces Closing of Public Offering	NASDAQ:ALEC	Alector Inc
19/01/2024	05:04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ALEC	Alector Inc
17/01/2024	07:54	GlobeNewswire Inc.	Alector Announces Pricing of Public Offering of Common Stock	NASDAQ:ALEC	Alector Inc
16/01/2024	15:01	GlobeNewswire Inc.	Alector Announces Proposed Public Offering of Common Stock	NASDAQ:ALEC	Alector Inc
28/11/2023	06:00	GlobeNewswire Inc.	Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs	NASDAQ:ALEC	Alector Inc
08/11/2023	06:00	GlobeNewswire Inc.	Alector to Participate in the Stifel Healthcare Conference	NASDAQ:ALEC	Alector Inc
07/11/2023	15:05	GlobeNewswire Inc.	Alector Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ALEC	Alector Inc
27/10/2023	06:00	GlobeNewswire Inc.	Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)	NASDAQ:ALEC	Alector Inc
07/09/2023	06:00	GlobeNewswire Inc.	Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease	NASDAQ:ALEC	Alector Inc
03/08/2023	15:05	GlobeNewswire Inc.	Alector Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ALEC	Alector Inc
27/07/2023	07:30	GlobeNewswire Inc.	Alector to Host Mid-Year Earnings Conference Call	NASDAQ:ALEC	Alector Inc
15/06/2023	15:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALEC	Alector Inc
15/06/2023	15:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALEC	Alector Inc
06/06/2023	06:00	GlobeNewswire Inc.	Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference	NASDAQ:ALEC	Alector Inc
01/06/2023	18:35	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:ALEC	Alector Inc
04/05/2023	15:20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ALEC	Alector Inc
04/05/2023	15:05	GlobeNewswire Inc.	Alector Reports First Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ALEC	Alector Inc
02/05/2023	07:31	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALEC	Alector Inc